Maria Ripol heads Open Innovation and Digital Transformation at Barcelona Health Hub, one of Europe's most active health innovation institutions, based inside the historic Hospital de Sant Pau. She didn't arrive there through a medical degree or a tech background, she came through international relations, public policy.

In this episode we talk about what open innovation actually looks like from the inside; the daily reality of connecting startups, hospitals, pharma, investors, and insurers, and why that job is as much about managing expectations as it is about making connections. We get into what separates a health startup that is ready from one that isn't, why regulation might be less of a wall and more of a competitive advantage, and what AI is genuinely doing well in health versus where the hype is running ahead of the reality.

An honest conversation with someone who has had a front row seat to Barcelona's health innovation scene and isn't afraid to say what she actually thinks.

Recorded in Barcelona.

Aline Noizet has been inside Barcelona's health tech ecosystem since the beginning, when wearables were just about counting steps and hospitals had no idea what digital health meant. Fifteen years later, she is one of the most connected people in the space, and in this episode she reflects on everything she has witnessed along the way.

We talk about how the ecosystem was built and who built it, what makes a health startup succeed or quietly disappear, and what the full journey of a digital health product actually looks like from idea to reimbursement. We also get into femtech and why women's health is still fighting for the funding and attention it deserves, the real state of prevention and precision medicine, and where she sees healthcare going in the next ten years.

A conversation with someone who has seen it all, and still believes the best is ahead.

Recorded in Barcelona. Visit Youtube for a video version.

Market access is the invisible bridge between a health technology being approved and a patient actually using it.

In this episode of the Health Innovation Playground, we sit down with Chus Castillo — a biologist-turned-strategist with over 25 years at Roche, GSK, and Pfizer, now leading market access and pricing consulting at IGES Spain.

We unpack what market access actually means day-to-day (hint: five key questions every innovator must answer), how the rules differ dramatically between Europe, the US, and China, and why pricing is no longer just a number — it's a tool of national policy.

We also get into the quiet revolution happening in Health Technology Assessment, where social impact and environmental sustainability are starting to count alongside clinical evidence.

For entrepreneurs: Chus is direct — your product will not sell itself, no matter how good your data is. Here's what you actually need.

Recorded at IGES Spain, Barcelona

This is the Health Innovation Playground , with Yousef H. Ahmed MD

Substack: ⁠https://healthinnovationplayground.substack.com/⁠

Connect with Yousef: ⁠https://www.linkedin.com/in/yousef-h-ahmed-368b79103/⁠